IN2014MN01432A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN01432A IN2014MN01432A IN1432MUN2014A IN2014MN01432A IN 2014MN01432 A IN2014MN01432 A IN 2014MN01432A IN 1432MUN2014 A IN1432MUN2014 A IN 1432MUN2014A IN 2014MN01432 A IN2014MN01432 A IN 2014MN01432A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/02—Carbamic acids; Salts of carbamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/26—Polyhydroxylic alcohols containing only six-membered aromatic rings as cyclic part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/36—Polyhydroxylic alcohols containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161580409P | 2011-12-27 | 2011-12-27 | |
| PCT/KR2012/011470 WO2013100567A1 (en) | 2011-12-27 | 2012-12-26 | Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01432A true IN2014MN01432A (en) | 2015-07-03 |
Family
ID=48655156
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1432MUN2014 IN2014MN01432A (en) | 2011-12-27 | 2014-07-15 | |
| IN1436MUN2014 IN2014MN01436A (en) | 2011-12-27 | 2014-07-15 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1436MUN2014 IN2014MN01436A (en) | 2011-12-27 | 2014-07-15 |
Country Status (13)
| Country | Link |
|---|---|
| US (6) | US20130203846A1 (en) |
| EP (6) | EP2797877A4 (en) |
| JP (8) | JP6089045B2 (en) |
| KR (6) | KR101795562B1 (en) |
| CN (6) | CN104136415B (en) |
| AU (2) | AU2012360362B2 (en) |
| BR (2) | BR112014015482A8 (en) |
| CA (2) | CA2858977C (en) |
| ES (3) | ES2624989T3 (en) |
| IN (2) | IN2014MN01432A (en) |
| MX (2) | MX353024B (en) |
| RU (2) | RU2014124029A (en) |
| WO (6) | WO2013100566A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
| KR101795562B1 (en) * | 2011-12-27 | 2017-11-08 | (주)바이오팜솔루션즈 | Phenyl carbamate compounds for use in preventing or treating stroke |
| KR101717872B1 (en) | 2013-03-12 | 2017-03-17 | (주)바이오팜솔루션즈 | Phenyl carbamate compounds for use in preventing or treating pediatric epilesy and epilesy-related syndromes |
| CN105209430B (en) * | 2013-03-12 | 2019-09-13 | 比皮艾思药物研发有限公司 | Carbanilate compound and neuroprotective composition comprising it |
| CN106507667B (en) * | 2013-12-12 | 2020-01-24 | 比皮艾思药物研发有限公司 | Sulfamate derivatives for the prevention or treatment of epilepsy |
| KR101792998B1 (en) * | 2013-12-12 | 2017-11-02 | (주)바이오팜솔루션즈 | Sulfamate derivative compounds for use in treating or alleviating pain |
| BR112018067663B1 (en) * | 2016-02-29 | 2023-01-10 | Bio-Pharm Solutions Co., Ltd | SULFAMATE DERIVATIVE COMPOUNDS, THEIR USES AND PHARMACEUTICAL COMPOSITION |
| WO2019079242A1 (en) | 2017-10-16 | 2019-04-25 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
| KR102005019B1 (en) | 2018-04-04 | 2019-07-31 | 한국과학기술연구원 | A composition for preventing and treating stroke |
| JP2021529513A (en) | 2018-07-02 | 2021-11-04 | ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | Treatment of amyotrophic lateral sclerosis and spinal cord-related disorders |
| US20210361318A1 (en) | 2018-07-02 | 2021-11-25 | Voyager Therapeutics, Inc. | Cannula system and use thereof |
| KR102427769B1 (en) | 2020-08-07 | 2022-08-02 | 한국과학기술연구원 | Composition for prevention or treatment of multiple sclerosis |
| KR102531540B1 (en) | 2020-09-18 | 2023-05-16 | 한국과학기술연구원 | Composition for prevention or treatment of rheumatoid arthritis |
| KR102614653B1 (en) | 2021-06-09 | 2023-12-20 | 한국과학기술연구원 | Novel heterocyclyl-phenyl-methylamine derivatives, preparation method thereof, and use thereof for preventing, improving, or treating multiple sclerosis |
| CA3227793A1 (en) | 2021-08-05 | 2023-02-09 | Yong Moon Choi | Phenyl carbamate crystalline form and method for preparing same |
| KR102399807B1 (en) * | 2021-08-05 | 2022-05-20 | (주)바이오팜솔루션즈 | Phenylcarbamate crystalline form and method for manufacturing the same |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2884444A (en) | 1956-01-13 | 1959-04-28 | Carter Prod Inc | 2-phenyl-1,3 propane diol dicarbamate |
| US2937119A (en) | 1959-06-11 | 1960-05-17 | Carter Prod Inc | Nu-monosubstituted-2, 2-dialkyl-1, 3-propanediol dicarbamates |
| US3313692A (en) | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3313699A (en) * | 1962-06-26 | 1967-04-11 | Armour Pharma | Compositions for and method of treating the central nervous system |
| US3313696A (en) | 1962-06-26 | 1967-04-11 | Armour Pharmacentical Company | Carbamate sedative compositions and method of use |
| US3265727A (en) | 1962-06-26 | 1966-08-09 | Armour Pharma | Phenyl alkyl-1, 2 dicarbamates |
| US3313700A (en) * | 1962-07-18 | 1967-04-11 | Armour Pharmacentical Company | Method of treating the central nervous system with substituted phenethyl carbamates and compositions therefor |
| US3265728A (en) | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| FR5671M (en) * | 1965-04-23 | 1968-01-02 | ||
| US3600427A (en) | 1967-05-08 | 1971-08-17 | Anthony J Verbiscar | Phenyl carbamate latentiated phenethylamines |
| JPS61271992A (en) * | 1985-05-28 | 1986-12-02 | Central Glass Co Ltd | Production of optically active diol |
| AU6765394A (en) * | 1993-05-25 | 1994-12-20 | Avondale Chemical Company | Process for preparing felbamate and intermediates thereto |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| US20010034365A1 (en) * | 1996-01-16 | 2001-10-25 | Choi Yong Moon | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| US6242468B1 (en) * | 1997-02-27 | 2001-06-05 | Jia-He Li | Carbamate and urea compositions and neurotrophic uses |
| US6642395B1 (en) * | 1999-11-29 | 2003-11-04 | Mitsubishi Rayon Co., Ltd. | Acetalsulfonate derivative, process for producing the same, and process for producing styrene oxide derivative |
| GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| RS51055B (en) * | 2001-02-27 | 2010-10-31 | Ortho-Mcneil Pharmaceutical Inc. | Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| PT1404312E (en) | 2001-02-27 | 2011-02-01 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in the treatment of pain |
| BR0208421A (en) | 2001-04-02 | 2004-03-30 | Astrazeneca Ab | Pharmaceutical formulation for mucosal administration to a patient, daily pharmaceutical dose, solid dispersion, use of pvp in solid dispersion with 4'-cyano-alpha ', alpha', alpha'-trifluoro-3- (4-fluoro phenylsulfonyl) - 2-hydroxy-2-methylpropiono-m-toluidide, and methods for increasing storage stability, bioavailability of the drug and for reducing the variation in plasma concentrations of 4'-cyano-alpha ', alpha', alpha ' , -trifluoro-3- (4-fluorophenylsulfonyl) -2-hydroxy-2-methylpropion-m-toluidide among patients |
| MXPA04000008A (en) | 2001-06-25 | 2004-05-21 | Sk Corp | Carbamates of 2-heterocyclic-1,2-ethanediols. |
| RS50948B (en) | 2001-07-16 | 2010-08-31 | Ortho-Mcneil Pharmaceutical Inc. | Carbamate compounds for use in preventing or treating neuropathic pain |
| EE05381B1 (en) * | 2001-12-21 | 2011-02-15 | Ortho-McNeil�Pharmaceutical,�Inc. | Process for the Preparation of 2- (Substituted-Phenyl) -2-H-Diacarbamates, Intermediate Compounds and Morpho-Formations of Carbamates |
| FR2836915B1 (en) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | AMINOINDAZOLE DERIVATIVES, PREPARATION METHOD AND INTERMEDIATES THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
| AU2003263574A1 (en) | 2002-05-31 | 2003-12-19 | Patel, Hetalkumar, Virendrabhai | A process for the preparation of phenylcarbamates |
| US6897217B2 (en) * | 2003-04-23 | 2005-05-24 | Schering Corporation | 2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists |
| WO2005044093A2 (en) * | 2003-11-05 | 2005-05-19 | Unimed Pharmaceuticals, Inc. | Delta-9- the treatment of multiple sclerosis |
| ATE461932T1 (en) * | 2004-04-21 | 2010-04-15 | Schering Corp | PYRAZOLOÄ4,3-EÜ-1,2,4-TRIAZOLOÄ1,5-CUPYRIMIDINES AS ANTAGONISTS OF THE ADENOSINE A2A RECEPTOR |
| NZ552336A (en) * | 2004-06-08 | 2010-12-24 | Families Of Spinal Muscular Atrophy | 2,4-Diaminoquinazolines for spinal muscular atrophy |
| ATE464044T1 (en) * | 2004-09-16 | 2010-04-15 | Janssen Pharmaceutica Nv | USE OF 2-PHENYL-1,2-ETHANEDIOL (DI)CARBAMATES FOR THE TREATMENT OF EPILEPTOGENesis |
| CN101076327A (en) * | 2004-10-15 | 2007-11-21 | 詹森药业有限公司 | Carbamate compounds for use in treating neurodegenerative disorders |
| US7442438B2 (en) | 2005-05-04 | 2008-10-28 | 3M Innovative Properties Company | Wet and dry stick adhesive, articles, and methods |
| TW200800954A (en) | 2006-03-16 | 2008-01-01 | Astrazeneca Ab | Novel crystal modifications |
| SA07280403B1 (en) * | 2006-07-28 | 2010-12-01 | إيساي أر أند دي منجمنت كو. ليمتد | Quaternary salt of cinnamide compound |
| CN101472913A (en) * | 2006-07-28 | 2009-07-01 | 卫材R&D管理有限公司 | Prodrug of cinnamide compound |
| US7632963B2 (en) * | 2006-10-06 | 2009-12-15 | Janssen Pharmaceutica Nv | Crystal of (S)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
| EP2089002A1 (en) * | 2006-10-13 | 2009-08-19 | Janssen Pharmaceutica, N.V. | Phenylalkyl carbamate compositions |
| BRPI0718316A2 (en) | 2006-10-27 | 2014-07-01 | Janssen Pharmaceutica Nv | PROCEDURES FOR TREATMENT OF COLLAR AND VESTIBULAR DISORDERS. |
| JP2010508355A (en) | 2006-10-30 | 2010-03-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | How to treat depression |
| PE20081775A1 (en) * | 2006-12-20 | 2008-12-18 | Bristol Myers Squibb Co | MACROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA |
| CN101679436A (en) * | 2007-04-10 | 2010-03-24 | Sgx药品公司 | Fused ring heterocycle kinase modulators |
| WO2009022345A1 (en) * | 2007-08-14 | 2009-02-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Phenyl carbamates for the treatment of multiple sclerosis |
| US20090105498A1 (en) * | 2007-10-18 | 2009-04-23 | Porstmann Frank | Improved process for preparing 2-(substituted phenyol)-2-hydroxy-ethyl-carbamates |
| AU2009282818A1 (en) | 2008-08-21 | 2010-02-25 | Richter Gedeon Nyrt. | Methods for treating neuropathic pain |
| JP2011219387A (en) * | 2010-04-06 | 2011-11-04 | Kaneka Corp | Method for producing ionic liquid |
| US9018253B2 (en) * | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
| CA2803825C (en) * | 2010-07-02 | 2015-12-29 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
| CA2815460C (en) * | 2011-01-13 | 2017-04-18 | Bio-Pharm Solutions Co., Ltd. | Process for preparation of phenyl carbamate derivatives |
| US9133187B2 (en) * | 2011-02-28 | 2015-09-15 | Array Biopharma Inc. | Serine/threonine kinase inhibitors |
| KR101795562B1 (en) * | 2011-12-27 | 2017-11-08 | (주)바이오팜솔루션즈 | Phenyl carbamate compounds for use in preventing or treating stroke |
-
2012
- 2012-12-26 KR KR1020147016928A patent/KR101795562B1/en active IP Right Grant
- 2012-12-26 KR KR1020147017116A patent/KR20140113919A/en not_active Application Discontinuation
- 2012-12-26 JP JP2014549992A patent/JP6089045B2/en active Active
- 2012-12-26 EP EP12861408.8A patent/EP2797877A4/en not_active Withdrawn
- 2012-12-26 BR BR112014015482A patent/BR112014015482A8/en not_active Application Discontinuation
- 2012-12-26 ES ES12862488.9T patent/ES2624989T3/en active Active
- 2012-12-26 ES ES12862332T patent/ES2716832T3/en active Active
- 2012-12-26 EP EP12861302.3A patent/EP2797876A4/en not_active Withdrawn
- 2012-12-26 CN CN201280070738.4A patent/CN104136415B/en active Active
- 2012-12-26 JP JP2014549993A patent/JP6298765B2/en active Active
- 2012-12-26 JP JP2014549994A patent/JP2015504054A/en active Pending
- 2012-12-26 CN CN201280070692.6A patent/CN104136414A/en active Pending
- 2012-12-26 WO PCT/KR2012/011469 patent/WO2013100566A1/en active Application Filing
- 2012-12-26 JP JP2014549995A patent/JP6298766B2/en active Active
- 2012-12-26 AU AU2012360362A patent/AU2012360362B2/en active Active
- 2012-12-26 MX MX2014008020A patent/MX353024B/en active IP Right Grant
- 2012-12-26 WO PCT/KR2012/011474 patent/WO2013100570A1/en active Application Filing
- 2012-12-26 CA CA2858977A patent/CA2858977C/en active Active
- 2012-12-26 EP EP12862332.9A patent/EP2797879B1/en active Active
- 2012-12-26 WO PCT/KR2012/011470 patent/WO2013100567A1/en active Application Filing
- 2012-12-26 KR KR1020147020773A patent/KR101795563B1/en active IP Right Grant
- 2012-12-26 WO PCT/KR2012/011472 patent/WO2013100569A1/en active Application Filing
- 2012-12-26 KR KR1020147015403A patent/KR101880584B1/en active IP Right Grant
- 2012-12-26 RU RU2014124029A patent/RU2014124029A/en unknown
- 2012-12-26 CA CA2859129A patent/CA2859129C/en active Active
- 2012-12-26 WO PCT/KR2012/011471 patent/WO2013100568A1/en active Application Filing
- 2012-12-26 KR KR1020147017115A patent/KR20140113918A/en not_active Application Discontinuation
- 2012-12-26 JP JP2014549996A patent/JP2015504055A/en active Pending
- 2012-12-26 MX MX2014008021A patent/MX338554B/en active IP Right Grant
- 2012-12-26 CN CN201280070646.6A patent/CN104136413B/en active Active
- 2012-12-26 EP EP12862021.8A patent/EP2797878B1/en active Active
- 2012-12-26 CN CN201280070737.XA patent/CN104870421A/en active Pending
- 2012-12-26 RU RU2014124028A patent/RU2632659C2/en active
- 2012-12-26 ES ES12863856T patent/ES2710902T3/en active Active
- 2012-12-26 JP JP2014549991A patent/JP6155280B2/en active Active
- 2012-12-26 CN CN201280070782.5A patent/CN104136416B/en active Active
- 2012-12-26 CN CN201280070632.4A patent/CN104169253B/en active Active
- 2012-12-26 KR KR1020147017965A patent/KR101862203B1/en active IP Right Grant
- 2012-12-26 EP EP12862488.9A patent/EP2797880B1/en active Active
- 2012-12-26 BR BR112014015568-2A patent/BR112014015568B1/en active IP Right Grant
- 2012-12-26 EP EP12863856.6A patent/EP2797881B1/en active Active
- 2012-12-26 AU AU2012360365A patent/AU2012360365B2/en active Active
- 2012-12-26 WO PCT/KR2012/011475 patent/WO2013100571A1/en active Application Filing
- 2012-12-27 US US13/727,661 patent/US20130203846A1/en not_active Abandoned
- 2012-12-27 US US13/727,659 patent/US9029589B2/en active Active
- 2012-12-27 US US13/727,663 patent/US9162975B2/en active Active
- 2012-12-27 US US13/727,656 patent/US20130184338A1/en not_active Abandoned
- 2012-12-27 US US13/727,654 patent/US9624164B2/en active Active
- 2012-12-27 US US13/727,665 patent/US9034848B2/en active Active
-
2014
- 2014-07-15 IN IN1432MUN2014 patent/IN2014MN01432A/en unknown
- 2014-07-15 IN IN1436MUN2014 patent/IN2014MN01436A/en unknown
-
2017
- 2017-07-21 JP JP2017141920A patent/JP2017193577A/en active Pending
-
2018
- 2018-01-10 JP JP2018001648A patent/JP2018108996A/en active Pending